1. A novel methylation-detection panel for HPV associated high-grade squamous intraepithelial lesion and cervical cancer screening
- Author
-
Xiaobo Cheng, Ranran Chai, Teng Zhang, Yanjie Chen, Fangqin Fan, Yingfei Ye, Guanqin Jin, Tingting Li, Hui Wang, Jingwen Ding, Min Zheng, Yanhua Han, Qinzhu Tang, Zhiqing Song, Yiqun Ji, Wengweng Song, Weifeng Luo, and Yu Kang
- Subjects
DNA methylation detection ,Early screening ,Cervical squamous intraepithelial lesion ,Cervical cancer ,Medicine ,Science - Abstract
Abstract Cervical cancer (CC) was considered to be the most common gynaecological cancer, with an estimated 342,000 deaths worldwide each year, as the majority of patients were diagnosed at an advanced stage of the disease. The purpose of this study was to evaluate the predictive value of multi-locus methylation assay for the early detection of CC. The cervical exfoliated cell samples from 492 HPV-positive females with cervical lesions were collected and subjected to methylation detection of gene FAM19A4, EPB41L3 and PAX1 after bisulfite conversion. The levels of gene methylation in patients with different severity of cervical lesions were evaluated and compared. The receiver-operating characteristic (ROC) curve was established and efficacy indexes such as sensitivity, specificity and area under the curve (AUC) were calculated to assess the diagnostic value of DNA methylation detection at multiple gene loci for CC. The methylation levels of FAM19A4, EPB41L3 and PAX1 were significantly increased with the grade of cervical squamous intraepithelial lesions. The sensitivities of FAM19A4, EPB41L3 and PAX1 alone for high-grade squamous intraepithelial lesion (HSIL) and CC diagnosis were 84.6%, 86.3% and 88.0%, respectively; when three markers were combined by a logistic regression model, the sensitivity was 88.0%, with a high specificity of 97.7% and AUC of 0.957 (95% CI 0.937–0.977). Methylation status of FAM19A4, EPB41L3 and PAX1 were highly specific and effective for monitoring the progression of cervical lesions and the tri-gene methylation assay could be used as a triage tool for CC early screening.
- Published
- 2024
- Full Text
- View/download PDF